MicroTech Medical (Hangzhou) Co., Ltd. (02235) disclosed that on 09 February 2026, a total of 26,000 H shares were repurchased on the Hong Kong Stock Exchange at prices ranging between HKD 7.26 and HKD 7.33 per share, with an aggregate repurchase payment of HKD 190,312. These shares were designated as treasury shares and increased the total treasury share count to 3,432,800, while the number of issued shares (excluding treasury shares) decreased to 165,743,042. The total issued share count remained at 169,175,842.

The company repurchased these shares under a mandate approved on 28 May 2025 for up to 16,668,364 shares. As of this repurchase, 880,600 shares had been repurchased under that mandate, representing 0.5283% of the number of issued shares (excluding treasury shares) at the time of approval. In accordance with relevant listing rules, no new shares or treasury share sales may be announced or effected until 09 March 2026 without prior approval from the Hong Kong Stock Exchange.